SGRT in Head and Neck Cancer Radiotherapy
- Sponsor
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- Study ID
- NCT07726407
- Status
- Recruiting
Conditions
- Head and Neck Cancer
- Radiotherapy, Conformal (IMRT)
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 75 Years
- Healthy Volunteers
- Not accepted
Interventions
- SGRT-guided radiotherapy with open thermoplastic mask immobilization — DEVICEPatients undergo simulation and treatment using an open-face head-neck-shoulder thermoplastic mask. Before and during each fraction, the surface-guided system monitors the patient's surface position in real-time. Positioning is adjusted based on SGRT data and verified by pre-treatment CBCT.
- Closed head-neck-shoulder thermoplastic mask with laser alignment — DEVICEPatients undergo simulation and treatment using a standard closed head-neck-shoulder thermoplastic mask. Positioning is performed using traditional laser marks and skin tattoos, with position verified by pre-treatment CBCT. No optical surface system is used for active monitoring.
Study Details
This study is a prospective, randomized, open-label, single-center exploratory trial. A total of 40 newly diagnosed, untreated head and neck cancer patients (stage I-IVa, AJCC 8th edition) will be enrolled and randomly assigned in a 1:1 ratio to either the experimental group or the control group. The experimental group will receive radiotherapy immobilization using optical surface guidance technology combined with an open-face mask, while the control group will undergo conventional positioning with a closed head-neck-shoulder thermoplastic mask. The primary objective is to compare the six-dimensional setup errors derived from cone-beam CT (CBCT) registration and intrafraction motion between the two groups. The secondary objective is to compare dosimetric parameters of organs at risk (including lens, eyeball, spinal cord, brainstem, temporal lobe, parotid gland, submandibular gland, thyroid gland, mandible, and temporomandibular joint) between the two groups. The safety of the optical surface-guided open-face mask technique will be evaluated by monitoring radiotherapy-related adverse effects during and after treatment. This study aims to investigate whether optical surface guidance combined with open-face immobilization can improve patient comfort, provide more precise radiotherapy, and enhance the protection of normal tissues.
Key Dates
- First listed
- Jul 24, 2026
- Start date
- Jun 15, 2026
- Status verified
- May 2026
- Primary completion
- Dec 30, 2028
- Completion
- Dec 30, 2028
Study Design
- Enrollment
- 40 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Optical Surface Guidance + Open-Face Mask GroupPatients undergo simulation and treatment using an open-face head-neck-shoulder thermoplastic mask. Before and during each fraction, the surface-guided system monitors the patient's surface position in real-time. Positioning is adjusted based on SGRT data and verified by pre-treatment CBCT.
- Active Comparator: Conventional Positioning + Closed Mask GroupPatients undergo simulation and treatment using a standard closed head-neck-shoulder thermoplastic mask. Positioning is performed using traditional laser marks and skin tattoos, with position verified by pre-treatment CBCT. No optical surface system is used for active monitoring.
Primary Outcome Measure
Six-Dimensional Setup Error [ Time Frame: First three times and weekly before each fraction during the entire radiotherapy course (typically 5-7 weeks). ]
Central Contacts
- Ye ling(020)36997353
Find similar trials
Related Studies
- Identification and Characterization of Novel Proteins and Genes in Head and Neck CancerRecruiting · Stanford University · Stanford, California
- Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung CancersRecruiting · Stanford University · Stanford, California
- Tissue Sample Collection From Patients With Head and Neck Cancer and From Healthy ParticipantsRecruiting · Vanderbilt University Medical Center · Nashville, Tennessee
- Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal VolunteersRecruiting · University of Colorado, Denver · Aurora, Colorado